Umrx stock forecast

So far this year, the stock has lost These targets would result in a 60 to 90 per cent capital gain by December, as long as the earnings estimate is hit. That said, since the company has missed the two recent rallies, it is unlikely that it will gain from any subsequent ones until the virus situation is contained and the fight between satellite and streaming resumes in a more levelled battlefield. You can always try to profit from any future price fluctuations, regardless of their direction by taking a long or a short position respectively.

Follow the latest stock market news and track the T live rates with Capital. Open a free practise account in less than 3 min. Indices Forex Commodities Cryptocurrencies. For traders. News and features Capital. Professional clients Institutional Economic calendar. Learn to trade. Commodities trading guide Forex trading guide Crypto trading guide Indices trading guide Trading strategies guide Trading psychology guide Glossary Courses. Why Capital. Our Global Offices Is Capital.

Referral programme. Get the app. Log In Trade Now. My account. Alejandro Arrieche15 May Analysis. Share Article. Charts currently unavailable. Grab a coffee. Refresh and try again. Open a trading account in less than 3 min Open Now.

Open a free practise account in less than 3 min Open Now. Latest video. Fear index: off the worst but still running high by Dan Atkinson.

UMRX Stock Forecast

GE stock price forecast: the bull party ended many years ago by Jayson Derrick. Try Capital. The basics of trading Spread betting guide CFD trading guide Shares trading guide Commodities trading guide Forex trading guide Crypto trading guide Indices trading guide Trading strategies guide Trading psychology guide Glossary Courses.

Contact support.As of late, it has definitely been a great time to be an investor in Unum Therapeutics Inc. Yahoo Finance. Sign in. Sign in to view your mail. Finance Home. Unum Therapeutics Inc. Currency in USD. Add to watchlist. Summary Company Outlook. Trade prices are not sourced from all markets.

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies. Bullish pattern detected. Commodity Channel Index. View all chart patterns. Performance Outlook Short Term. Mid Term. Long Term.

Unum Therapeutics Inc. - UMRX Stock Chart Technical Analysis for 07-07-2020

Previous Close 3. Volume 2, Market Cap Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Research that delivers an independent perspective, consistent methodology and actionable insight. Press Releases. New Strong Sell Stocks for July 9th. Advertise With Us. All rights reserved. Data Disclaimer Help Suggestions. Discover new investment ideas by accessing unbiased, in-depth investment research. Day's Range. Beta 5Y Monthly. Earnings Date. May 11, Ex-Dividend Date.In last trading session, Unum Therapeutics Inc.

For Unum Therapeutics Inc. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None analyst s advised it as an Underweight. Upright in the green today for gaining Unum Therapeutics Inc. Number of shares sold short was Statistics highlight that Unum Therapeutics Inc. The company lessened Apart from that, the company came raising its revenue forecast for fiscal year The company is estimating its revenue growth to increase by This year revenue growth is estimated to drop Insiders are in possession of Investors also watch the number of corporate investors in a company very closely, which is 33 institutions for Unum Therapeutics Inc.

And as of March 30,it was holding Sign in. Log into your account. Forgot your password? Password recovery.

umrx stock forecast

Recover your password. Tuesday, July 14, Get help. Marketing Sentinel. Investor confidence shakens after Aileron Therapeutics, Inc. TTI investors to reap big returns again.

umrx stock forecast

Short term estimates and forecasts for Eldorado Resorts, Inc. Marketing Sentinel is a free online newspaper packed with exclusive content, news, articles and much more! The information agency "Marketing Sentinel" was established at the end of Its founder and leader is Lewis Roberts.

IA "Marketing Sentinel" seeks to provide the news and analytical information to both American and foreign audiences, events and events in the USA and all over the world reliably, objectively and promptly. Contact us: contact marketingsentinel. EVOP April 28, April 28, Why should you add Trinseo S. TSE to your portfolio?Sign Up to See Ratings Ranked of in Medical - Pharmaceuticals. Unum Therapeutics Inc. Its lead product candidate is the ACTR used in combination with rituximab, which is in Phase I clinical trials to treat adult patients with relapsed or refractory non-Hodgkin lymphoma.

It has strategic collaboration with Seattle Genetics, Inc. The company was founded in and is based in Cambridge, Massachusetts. Below are the latest news stories about Unum Therapeutics Inc that investors may wish to consider to help them evaluate UMRX as an investment opportunity.

Earlier this week, Unum completed its acquisition As of late, it has definitely been a great time to be an investor in Unum Therapeutics Inc. Each Series A share may Join thousands of investors who get the latest news, insights and top rated picks from StockNews. Revenue growth over the past 12 months for Unum Therapeutics Inc comes in at In terms of volatility of its share price, UMRX is more volatile than To visit the company's web site, go to www.

YTD Get Free Updates. Seeking Alpha July 10, Yahoo July 9, Yahoo July 8, Seeking Alpha July 6, Unum Therapeutics Inc. The UMRX stock price is The 3-month trading volume is 2. The consensus among analysts is that Unum Therapeutics Inc.

UMRX is a Buy stock at the moment, with a recommendation rating of 3.

None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. Figures show that Unum Therapeutics Inc. Other than that, the company has, however, increased its growth outlook for the fiscal year revenue. Growth estimates for the current quarter are Revenue growth from the last financial year stood is estimated to be As of March 30,the former fund manager holds about 1.

Sign in. Log into your account. Forgot your password? Password recovery. Recover your password. Tuesday, July 14, Get help. Marketing Sentinel. UMRX to your portfolio? How is the INmune Bio, Inc. Wrap Technologies, Inc. SNDL into becoming a top stock for investors. Entercom Communications Corp.

ETM : What is good about stock? When is BioCryst Pharmaceuticals, Inc.We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Don't Know Your Password?

ZacksTrade and Zacks. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. OK Cancel. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Home - Zacks Rank resources in one place. Zacks Premium - The only way to fully access the Zacks Rank. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. As an investor, you want to buy stocks with the highest probability of success. Industry: Medical - Biomedical and Genetics. View All Zacks 1 Ranked Stocks. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank Agreement, Magnitude, Upside and Surprise ; provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock.

umrx stock forecast

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Learn more about Zacks Equity Research reports. See more Zacks Equity Research reports.We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Don't Know Your Password?

ZacksTrade and Zacks. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. OK Cancel. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it?

Unum Therapeutics Inc Stock Forecast and Price Prognosis Data for 2020

See rankings and related performance below. Zacks Rank Home - Zacks Rank resources in one place. Zacks Premium - The only way to fully access the Zacks Rank. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum.

As an investor, you want to buy stocks with the highest probability of success. Industry: Medical - Biomedical and Genetics. View All Zacks 1 Ranked Stocks.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank Agreement, Magnitude, Upside and Surprise ; provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Learn more about Zacks Equity Research reports.

Unum Therapeutics Inc. (UMRX): Price and Financial Metrics

See more Zacks Equity Research reports. An industry with a larger percentage of Zacks Rank 1's and 2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank 4's and 5's. Research for UMRX? The Price and Consensus chart displays the company's stock price along with the consensus estimate.

Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast.

I accept X. Close this window. If you wish to go to ZacksTrade, click OK.

Unum Therapeutics Inc. (UMRX)

If you do not, click Cancel. Back to top. Zacks Rank:? Style Scores:? Industry Rank:?


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *